48 results on '"Le Du, Fanny"'
Search Results
2. Development of sensitive and robust multiplex digital PCR assays for the detection of ESR1 mutations in the plasma of metastatic breast cancer patients
3. Tucatinib Combination Treatment After Trastuzumab-Deruxtecan in Patients With ERBB2-Positive Metastatic Breast Cancer
4. Safety and efficacy of nivolumab, an anti-PD1 immunotherapy, in patients with advanced basal cell carcinoma, after failure or intolerance to sonic Hedgehog inhibitors: UNICANCER AcSé NIVOLUMAB trial
5. Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer
6. Histoire et innovation : chimiothérapie néoadjuvante des cancers du sein
7. Plasma‐based analysis of ERBB2 mutational status by multiplex digital PCR in a large series of patients with metastatic breast cancer
8. The role of tyrosine kinase inhibitors in the treatment of HER2+ metastatic breast cancer
9. Selective internal radiation therapy in older patients with hepatocellular carcinoma: a retrospective analysis
10. Development of multiplex digital PCR assays for the detection of PIK3CA mutations in the plasma of metastatic breast cancer patients
11. Therapeutic innovations in breast cancer
12. Paraneoplastic cerebellar degeneration associated with anti-Yo antibodies in uterine papillary serous carcinoma
13. Implications of BRCA Germline Mutations on Breast Cancer Medical Treatment
14. Prognostische Faktoren bei Patientinnen mit Mammakarzinom und leptomeningealen Metastasen: eine Subanalyse des deutschen Registers für Hirnmetastasen beim Mammakarzinom – Versorgungsforschungspreis der DGS 2023 – eine Kurzübersicht
15. Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program
16. Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experience
17. Management of trophoblastic tumors : review of evidence, current practice, and future directions
18. Effect of 21-Gene RT-PCR Assay on Adjuvant Therapy and Outcomes in Patients With Stage I Breast Cancer
19. Impact of clinical trial on survival outcomes
20. Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT.
21. Refining Therapy in Patients with HER2-Positive Breast Cancer with Central Nervous System Metastasis
22. Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer
23. Corrigendum to ‘The role of tyrosine kinase inhibitors in the treatment of HER2+ metastatic breast cancer’ [European Journal of Cancer 154 (2021) 175-189]
24. Breast Cancer Biomarkers: Utility in Clinical Practice
25. Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer: A Systematic Review and Network Meta-analysis
26. Targeted therapies in triple-negative breast cancer: failure and future
27. Volumetric Changes after 90Y Radioembolization for Hepatocellular Carcinoma in Cirrhosis: An Option to Portal Vein Embolization in a Preoperative Setting?
28. Impact of EPclin on adjuvant therapeutic decision making and comparison of EPclin to the PREDICT tool
29. Selective internal radiation therapy in older patients with hepatocellular carcinoma: a retrospective analysis.
30. Association immunothérapie et chimiothérapie : vers un nouveau standard dans les cancers du sein triple négatifs.
31. Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis
32. Tivozanib for hepatocellular carcinoma: not likely a new option
33. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy
34. UCBG 2-04: Long-term results of the PACS 04 trial evaluating adjuvant epirubicin plus docetaxel in node-positive breast cancer and trastuzumab in the human epidermal growth factor receptor 2–positive subgroup
35. Long-Term Outcomes in Patients with PET-Predicted Poor-Responsive HER2-Positive Breast Cancer Treated with Neoadjuvant Bevacizumab Added to Trastuzumab and Docetaxel: 5-Year Follow-Up of the Randomised AVATAXHER Study
36. Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experience
37. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
38. Characteristics of the Metastatic Breast Cancer Population with PIK3CA Mutation in the Randomized Phase II Study SAFIR02 Breast (UCBG-0105/1304)
39. BP67 - Characteristics of the Metastatic Breast Cancer Population with PIK3CA Mutation in the Randomized Phase II Study SAFIR02 Breast (UCBG-0105/1304)
40. EpCAM-independent isolation of EMT- circulating tumor cells in patients with primary breast cancer who receive primary systemic therapy.
41. Could any pT1a,bN0M0 hormone-responsive, invasive breast carcinomas be safely treated without endocrine therapy?
42. Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?
43. Abstract P4-01-10: Predictive impact of circulating tumor cells with an epithelial-to-mesenchymal transition phenotype in patients with primary breast cancer treated with primary systemic therapy
44. Impact of 21-gene RT-PCR assay on adjuvant therapy for stage I breast cancer.
45. Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer.
46. Glass Microspheres 90Y Selective Internal Radiation Therapy and Chemotherapy as First-Line Treatment of Intrahepatic Cholangiocarcinoma.
47. Volumetric Changes after Y Radioembolization for Hepatocellular Carcinoma in Cirrhosis: An Option to Portal Vein Embolization in a Preoperative Setting?
48. Haemolytic uremic syndrome and gemcitabine: jaundice is not always progression in cholangiocarcinoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.